INDSWIFT LABORATORIES
Back to Cashflow Statement
|
INDSWIFT LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹142 Cr | ₹72 Cr | ₹681 Cr | ₹-186 Cr | ₹-141 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDSWIFT LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹142 Cr |
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹681 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹-141 Cr |
How is Cash Flow from Financing Activities of INDSWIFT LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹142 Cr | 95.81 | |
| Mar2025 | ₹72 Cr | -89.36 | |
| Mar2024 | ₹681 Cr | Positive | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹-141 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,178.0 Cr | 3.4% | -0.7% | 259.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 3.4% |
-0.7% |
259.9% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses